Cryosite Limited (ASX:CTE)
Australia · Delayed Price · Currency is AUD 1.090
-0.005 (-0.46%)
Apr 7, 2026, 9:59 AM AEST
Cryosite Market Cap
Cryosite has a market cap or net worth of 53.2 million as of April 7, 2026. Its market cap has increased by 68.99% in one year.
Market Cap
53.20M
Enterprise Value
59.48M
Revenue
15.75M
Ranking
n/a
PE Ratio
25.39
Stock Price
1.09
Market Cap Chart
Since May 9, 2002, Cryosite's market cap has increased from 18.00 to 53.20M, an increase of 295,568,922.22%. That is a compound annual growth rate of 86.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 53.20M | 9.00% |
| Dec 29, 2025 | 48.81M | 17.65% |
| Dec 27, 2024 | 41.49M | 40.50% |
| Dec 29, 2023 | 29.53M | -17.12% |
| Dec 30, 2022 | 35.63M | 56.99% |
| Dec 31, 2021 | 22.70M | 22.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 837.78M |
| Australian Clinical Labs | 380.63M |
| Healius | 377.59M |
| Monash IVF Group | 257.16M |
| Rhythm Biosciences | 63.66M |
| INOVIQ | 48.57M |
| Microba Life Sciences | 41.41M |
| BCAL Diagnostics | 36.50M |